This article is outdated. (January 2014)
ATC code None
C 9 H 12 N 6 O 3
Molecular mass 252.23 g/mol
(what is this?) (verify)
Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV/AIDS. It was discovered by Raymond F. Schinazi ( Emory University) and C.K. Chu ( University of Georgia). It is being developed by RFS Pharma. Currently, it is in [1 ] Phase II clinical studies.
References [ edit ]
^ "Amdoxovir". AIDSmeds.com. January 13, 2009. Archived from the original on March 21, 2008 . Retrieved . March 21, 2008
External links [ edit ]
Murphy RL, Kivel NM, Zala C, Ochoa C, Tharnish P, Mathew J, Pascual ML, Schinazi RF (2010). "Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals". Antivir Ther 15 (2): 185–192. doi: 10.3851/IMP1514. PMID 20386073.